Literature DB >> 23850850

Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.

Baowei Zhang1, Wenhui Peng, Hailing Li, Yuyan Lu, Jianhui Zhuang, Ke Wang, Yang Su, Yawei Xu.   

Abstract

OBJECTIVE: Previous studies suggested that decreased serum vaspin levels were associated with coronary artery disease (CAD). The present study aimed to investigate the association between plasma vaspin levels and different states of CAD. DESIGN AND METHODS: A total of 162 patients with coronary angiography (CAG) proved that CAD was enrolled. Additional 103 patients complained with "chest discomfort" with negative CAG, and 60 normal subjects were enrolled in this study. The levels of plasma vaspin, adiponectin, clinical parameters, lipid profile and C reactive protein (CRP) were measured.
RESULTS: The levels of plasma vaspin were significantly lower in the CAD group (0.47±0.63 μg/L) than those in the healthy group and CAG (-) group (all p<0.001). In CAD group, the pos hoc analysis showed that serum vaspin concentration in acute myocardial infarction group (0.21±0.19 μg/L) was significantly lower than that in the unstable angina pectoris group (0.40±0.37 μg/L) (p=0.012), and serum vaspin concentration in unstable angina pectoris was significantly lower than that in stable angina pectoris group (0.92±0.94 μg/L) (p=0.013). The plasma vaspin concentration was also negatively correlated with the severity of CAD (1-vessel: 0.86±0.90 μg/L; 2-vessel: 0.36±0.39 μg/L; 3-vessel: 0.21±0.16 μg/L). The plasma vaspin concentration in CAG (-) group with "chest discomfort" (1.93±2.57 μg/L) was similar to the healthy control group (2.18±3.49μg/L).
CONCLUSIONS: The plasma vaspin concentration correlated to the severity of CAD. Furthermore, plasma vaspin has a value of avoiding patients without CAD from unnecessary CAG.
© 2013.

Entities:  

Keywords:  2-hour post-load plasma glucose; ALT; AMI; Acute coronary syndrome; Acute myocardial infarction; BMI; CAD; CAG; CRP; Coronary artery disease; FPG; HC; HDL-C; HbA1c; LDL-C; LVEF; OR; PG2h; ROC; SAP; SD; TC; TG; TnT; UAP; Vaspin; WBC; acute myocardial infarction; alanine aminotransferase; body mass index; c reactive protein; coronary angiography; coronary artery disease; fasting plasma glucose; glycosylated hemoglobin; healthy control; high-density lipoprotein cholesterol; left ventricular ejection fraction; low-density lipoprotein cholesterol; odd risk; receiver operating characteristic; stable angina pectoris; standard deviation; total cholesterol; triglyceride; troponin T; unstable angina pectoris; white blood cell count

Mesh:

Substances:

Year:  2013        PMID: 23850850     DOI: 10.1016/j.clinbiochem.2013.06.028

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  8 in total

Review 1.  The Role of Adipocytokines in Coronary Atherosclerosis.

Authors:  Luca Liberale; Aldo Bonaventura; Alessandra Vecchiè; Matteo Casula; Franco Dallegri; Fabrizio Montecucco; Federico Carbone
Journal:  Curr Atheroscler Rep       Date:  2017-02       Impact factor: 5.113

2.  Assessment of Serum VASPIN Levels among Type 2 Diabetes Mellitus Patients with or without Acute Coronary Syndrome.

Authors:  Aswathy Jaya Sathyaseelan; Prashant Shankarrao Adole; Mukta Wyawahare; Rama Prakasha Saya
Journal:  J Clin Diagn Res       Date:  2016-12-01

3.  Association of Adiponectin Gene Polymorphisms With the Risk of Coronary Artery Disease in Patients With Nonalcoholic Fatty Liver Disease in a Chinese Han Population.

Authors:  Shui-Xian Du; Lin-Lin Lu; Yang Liu; Quan-Jiang Dong; Shi-Ying Xuan; Yong-Ning Xin
Journal:  Hepat Mon       Date:  2016-06-26       Impact factor: 0.660

4.  Vaspin inhibits cytokine-induced nuclear factor-kappa B activation and adhesion molecule expression via AMP-activated protein kinase activation in vascular endothelial cells.

Authors:  Chang Hee Jung; Min Jung Lee; Yu Mi Kang; Yoo La Lee; Hae Kyeong Yoon; Sang-Wook Kang; Woo Je Lee; Joong-Yeol Park
Journal:  Cardiovasc Diabetol       Date:  2014-02-12       Impact factor: 9.951

5.  Vaspin attenuates the progression of atherosclerosis by inhibiting ER stress-induced macrophage apoptosis in apoE‑/‑ mice.

Authors:  Ying Lin; Jianhui Zhuang; Hailing Li; Guofu Zhu; Shunping Zhou; Weiming Li; Wenhui Peng; Yawei Xu
Journal:  Mol Med Rep       Date:  2015-12-22       Impact factor: 2.952

6.  Anti-Atherogenic Effects of Vaspin on Human Aortic Smooth Muscle Cell/Macrophage Responses and Hyperlipidemic Mouse Plaque Phenotype.

Authors:  Kengo Sato; Remina Shirai; Maho Yamaguchi; Tomoyuki Yamashita; Koichiro Shibata; Taisuke Okano; Yusaku Mori; Taka-Aki Matsuyama; Hatsue Ishibashi-Ueda; Tsutomu Hirano; Takuya Watanabe
Journal:  Int J Mol Sci       Date:  2018-06-11       Impact factor: 5.923

7.  The Association and Pathogenesis of SERPINA3 in Coronary Artery Disease.

Authors:  Bo Li; Zhijun Lei; You Wu; Bingyu Li; Ming Zhai; Yuan Zhong; Peinan Ju; Wenxin Kou; Yefei Shi; Xianling Zhang; Wenhui Peng
Journal:  Front Cardiovasc Med       Date:  2021-12-08

8.  Plasma vaspin is an effective biomarker for evaluation of future cardiovascular events in patients with chest pain: a 5-year retrospective observational study.

Authors:  Shuya Ji; Wenxin Kou; Peipei Luan; Weixia Jian; Jianhui Zhuang; Xiaopeng Xu; Yifan Zhao; Hailing Li; Wenhui Peng
Journal:  Ann Transl Med       Date:  2020-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.